COMPARATIVE THROMBOLYTIC PROPERTIES OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR (RT-PA) AND OF 2 PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) RESISTANT GLYCOSYLATION VARIANTS IN A COMBINED ARTERIAL AND VENOUS THROMBOSIS MODEL IN THE DOG

被引：0
|
作者：
COLLEN, D
STASSEN, JM
REFINO, CJ
PAONI, WF
KEYT, BA
ROSKAMS, T
JANG, IK
LIJNEN, HR
GOLD, HK
BENNETT, W
机构：
[1] CATHOLIC UNIV LEUVEN,CTR THROMBOSIS & VASC RES,B-3000 LOUVAIN,BELGIUM
[2] CATHOLIC UNIV LEUVEN,DEPT PATHOL,B-3000 LOUVAIN,BELGIUM
[3] MASSACHUSETTS GEN HOSP,CARDIAC UNIT,BOSTON,MA 02114
[4] GENENTECH INC,DEPT CARDIOVASC PHARMACOL,S SAN FRANCISCO,CA 94080
来源：
THROMBOSIS AND HAEMOSTASIS | 1993年 / 69卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：841 / 841
页数：1
相关论文
共 50 条
  • [21] BIOLOGICAL EFFECTS OF INACTIVATION OF THE GENES FOR TISSUE-TYPE PLASMINOGEN-ACTIVATOR, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN MICE
    CARMELIET, P
    SCHOONJANS, L
    KIECKENS, L
    STASSEN, JM
    BRONSON, R
    COLLEN, D
    MULLIGAN, R
    FIBRINOLYSIS, 1993, 7 : 27 - 28
  • [22] BIOLOGICAL EFFECTS OF DISRUPTION OF THE TISSUE-TYPE PLASMINOGEN-ACTIVATOR, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENES IN MICE
    CARMELIET, P
    BOUCHE, A
    DECLERCQ, C
    JANSSEN, S
    POLLEFEYT, S
    WYNS, S
    MULLIGAN, RC
    COLLEN, D
    ATHEROSCLEROSIS III: RECENT ADVANCES IN ATHEROSCLEROSIS RESEARCH: THE THIRD SARATOGA INTERNATIONAL CONFERENCE ON ATHEROSCLEROSIS IN NEKOMA, 1995, 748 : 367 - 382
  • [23] LEIDEN FIBRINOLYSIS WORKING PARTY - BLOOD COLLECTION AND HANDLING PROCEDURES FOR ASSESSMENT OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1)
    KLUFT, C
    VERHEIJEN, JH
    FIBRINOLYSIS, 1990, 4 : 155 - 161
  • [24] INTERACTION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 ON THE SURFACE OF ENDOTHELIAL-CELLS
    SAKATA, Y
    OKADA, M
    NORO, A
    MATSUDA, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1988, 263 (04) : 1960 - 1969
  • [25] KINETIC-ANALYSIS OF THE INTERACTION BETWEEN PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    MASSON, C
    ANGLESCANO, E
    BIOCHEMICAL JOURNAL, 1988, 256 (01) : 237 - 244
  • [26] PLASMA CHANGES OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 DURING CORONARY THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    OTTANI, F
    GALVANI, M
    NICOLINI, FA
    RONCHI, A
    FERRINI, D
    RUSTICALI, F
    CIRCULATION, 1993, 88 (04) : 320 - 320
  • [27] Plasminogen-activator inhibitor-1 in (PAI-1) gastric cancer
    Tabuchi, Y
    Nakamura, T
    Miyamura, K
    Nakae, S
    PROGRESS IN GASTRIC CANCER RESEARCH 1997: PROCEEDINGS OF THE 2ND INTERNATIONAL GASTRIC CANCER CONGRESS, 1997, : 447 - 450
  • [28] ROLE OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN DIC
    MATSUDA, T
    ASAKURA, H
    SAITO, M
    JOKAJI, H
    UOTANI, C
    KUMABASHIRI, I
    MORISHITA, E
    YAMAZAKI, M
    THROMBOSIS RESEARCH, 1991, 63 (02) : 269 - 269
  • [29] PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) LEVELS IN LIVER-DISEASES - SIGNIFICANCE OF COMPLEX-FORMATION WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR (TPA) IN PLASMA
    YOSHIKAWA, Y
    SAKATA, Y
    MAEKAWA, H
    TODA, G
    OKA, H
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 394 - 394
  • [30] REGULATION OF THE THROMBOLYTIC POTENTIAL OF THE VASCULAR WALL BY PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1)
    LOSKUTOFF, DJ
    CANADIAN JOURNAL OF CARDIOLOGY, 1993, 9 : C12 - C14
12345